Lyrica

Pharma

Viatris' growth story hinges on M&A: analyst

As legacy Upjohn's business prospects in China and Japan remain unclear, M&A will be critical to Viatris' growth, one analyst says.
Angus Liu Nov 18, 2020 11:46am

EU clears merger of Mylan and Pfizer's Upjohn with conditions

Apr 23, 2020 11:14am

Pfizer’s bulked-up Viatris may not reap rewards: analysts

Jan 29, 2020 12:04pm

ICER lambasts AbbVie, Roche for 'unsupported' price hikes

Oct 8, 2019 10:50am

Pfizer's Lyrica market share crumbles under generic onslaught

Aug 19, 2019 9:59am

With its generic spinoff cash, will Pfizer step up its buying game?

Jul 30, 2019 10:53am